期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PARASITOLOGY RESEARCH LetPub Score 5.3
50 ratings
Rate
Reputation 6.3 Influence 4.1 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | PARASITOL RES | ||||||||||||||||||||||||||||
ISSN | 0932-0113 | ||||||||||||||||||||||||||||
E-ISSN | 1432-1955 | ||||||||||||||||||||||||||||
h-index | 84 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 5.60%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://www.springer.com/436 | ||||||||||||||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/436/3 | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | GERMANY | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 1928 | ||||||||||||||||||||||||||||
每年文章數 | 240每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 17.01% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0932-0113%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 6 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 95% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[PARASITOLOGY RESEARCH] 的評論 | 撰寫評論 |
作者: Vet_xu 領域: 农林科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-27 22:16:15 評論於 Submitted on August 1st, received reviewer's comments on September 12th for minor revisions; revised on September 26th and received acceptance notification on September 27th. The reviewer's comments were very constructive and the paper was accepted after revisions. Wishing everyone's articles will be published smoothly as well.(0) 讚! | Vet_xu |
作者: zhangzhang 領域: 农林科学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2024-07-21 17:36:09 評論於 This is too outrageous, it's no wonder it's a well-established journal.666(0) 讚! | zhangzhang |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:27:57 評論於 Please translate the following paragraph into English and Japanese, and use ":" and "(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:36:34 評論於 HIGHLIGHTS is a requirement for authors in Elsevier journals. Not all journals include HIGHLIGHTS. The information provided by HIGHLIGHTS can help readers decide whether to further read the paper more quickly than by looking at the abstract(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:40:16 評論於 How many characters should an abstract generally be limited to?(0) 讚! | 龙鳞孝礼 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 12:38:23 評論於 When do we need the highlights part?(0) 讚! | Darlene Pepys |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 22:39:40 評論於 Seeing an increase, optimistic about the future, what does everyone think?(0) 讚! | 凌霄高洁 |
作者: 岳家瑞丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-11-06 08:36:28 評論於 Review speed: 1.0 | Submission hit rate: 5.0 Experience sharing: Many people around me have mentioned that this magazine is becoming more selective, and the data from the boss shows that it has been receiving more articles recently, with an acceptance rate of less than 50%. There are too many people submitting in segments. Recently, I submitted an article and it was rejected directly, but the speed was quite fast, within a few days. However, the reason given was just one sentence saying that the plagiarism rate was 26%. After checking it myself, I found that most of the duplication was in the materials and methods section, so I guess the editor just didn't want it and used this as an excuse. Submitting articles is getting harder and harder(0) 讚! | 岳家瑞丽 |
作者: 两仪艳兵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-09-18 18:27:39 評論於 Next year's estimated IF is probably below 2 points(0) 讚! | 两仪艳兵 |
作者: 采阳超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-07-07 10:36:27 評論於 I have submitted two clinical articles to this magazine, and the first one was accepted in 21 days, while the second one was accepted in 15 days. I think the review process was quite fast(0) 讚! | 采阳超级甜 |
作者: 采阳超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-07-07 09:14:00 評論於 I feel that this magazine is very good(0) 讚! | 采阳超级甜 |
作者: 云居博敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-04-27 10:47:09 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Whether a submission can be accepted is closely related to the scope of the selected topic, in other words, the article must be suitable for the taste of this journal. It is easy if it is suitable, as the editors are quite responsible; If it is not suitable, it is not easy to force it to be published. In short, it is very important to select a journal according to the topic, and it is also very important to revise the paper according to the journal(0) 讚! | 云居博敏 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-02-08 13:01:41 評論於 The decision-making power to accept or not is in the hands of the Editor, and the external review system has major issues. Sometimes opinions are only two sentences. Do you think that is a suitable opinion for external review? Also, it will ask authors to cite this journal's Reference, so the impact factor will increase. This is clearly insider trading. The quality of the journal is very poor - the impact factor is artificially inflated(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-24 17:09:39 評論於 Very irresponsible magazine, waited for over two months, and the final review feedback was only one sentence: Comments for the Author: Reviewer #1: The structure and citation does not fulfil the requirements of Parasitol Res(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 13:17:58 評論於 This journal is now rated 2.5, which is a significant increase compared to last year. Is there a possibility for it to go up to 3?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-06-24 16:11:06 評論於 It will fall down next year. The citation is made by oneself(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-04 12:18:51 評論於 Submitted an article, but it's almost been 50 days now and it's still in the same status as the day of submission. The article hasn't been reviewed yet and the chief editor hasn't responded to my emails. I don't know what's going on, I'm really considering withdrawing my submission… Have any of you experienced a similar situation?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-09-19 12:32:54 評論於 This magazine is famous for its slow review process, but it has a high acceptance rate, although it never reaches 95%(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-09-06 19:55:46 評論於 Review Speed: 6.0 | Submission Acceptance Rate: 75.0 Experience Sharing: I have been reviewing manuscripts for four months now, the speed is a bit slow, but the acceptance rate is high(0) 讚! | 凌霄高洁 |
作者: 梦之三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-08-17 18:39:47 評論於 It has been three months since I submitted my article in May and I still haven't received the first review. I'm feeling frustrated(0) 讚! | 梦之三岁啦 |
作者: 小野寺晨阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-08-07 22:53:59 評論於 I am prepared to try(0) 讚! | 小野寺晨阳 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 09:43:20 評論於 Research focus: Parasites(0) 讚! | 凌霄高洁 |
作者: 稻妻士博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-05-21 11:42:06 評論於 I submitted a short communication in May this year, and it was accepted quite quickly. It was finalized within a week. The efficiency of the editor is really high!(0) 讚! | 稻妻士博 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us